- Home
- MGRM vs STRO Comparison
MGRM vs STRO Comparison
Compare MGRM & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- STRO
- Stock Information
- Founded
- MGRM 2016
- STRO 2003
- Country
- MGRM United States
- STRO United States
- Employees
- MGRM N/A
- STRO N/A
- Industry
- MGRM Medical/Dental Instruments
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MGRM Health Care
- STRO Health Care
- Exchange
- MGRM Nasdaq
- STRO Nasdaq
- Market Cap
- MGRM 79.9M
- STRO 77.7M
- IPO Year
- MGRM N/A
- STRO 2018
- Fundamental
- Price
- MGRM $5.83
- STRO $0.75
- Analyst Decision
- MGRM Strong Buy
- STRO Hold
- Analyst Count
- MGRM 1
- STRO 7
- Target Price
- MGRM $5.40
- STRO $3.97
- AVG Volume (30 Days)
- MGRM 810.3K
- STRO 1.2M
- Earning Date
- MGRM 08-13-2025
- STRO 08-12-2025
- Dividend Yield
- MGRM N/A
- STRO N/A
- EPS Growth
- MGRM N/A
- STRO N/A
- EPS
- MGRM N/A
- STRO N/A
- Revenue
- MGRM N/A
- STRO $66,434,000.00
- Revenue This Year
- MGRM N/A
- STRO N/A
- Revenue Next Year
- MGRM N/A
- STRO N/A
- P/E Ratio
- MGRM N/A
- STRO N/A
- Revenue Growth
- MGRM N/A
- STRO N/A
- 52 Week Low
- MGRM $1.92
- STRO $0.52
- 52 Week High
- MGRM $6.02
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- MGRM 93.59
- STRO 44.48
- Support Level
- MGRM $2.81
- STRO $0.73
- Resistance Level
- MGRM $6.02
- STRO $0.79
- Average True Range (ATR)
- MGRM 0.19
- STRO 0.06
- MACD
- MGRM 0.29
- STRO 0.00
- Stochastic Oscillator
- MGRM 94.70
- STRO 40.20
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.